Colon Cancer (Colorectal Cancer)
Colorectal cancer is the third most-common cancer and the second leading cause of cancer death in men and women in the United States, according to the Colon Cancer Alliance. Colon cancer is cancer of the large intestine, whereas rectal cancer is cancer of the last several inches of the colon. Together, they're referred to as colorectal cancers and often start as benign polyps that could be removed easily through colonoscopy.
Chemical in Peppers May Inhibit Colon Tumors
Researchers at the University of California, San Diego School of Medicine report that dietary capsaicin—the active ingredient in chili peppers—produces chronic activation of a receptor on cells lining the intestines of mice, triggering a reaction that ultimately ...More
Big Increase in Surgeon Training for da Vinci Colorectal Surgery
A record number of U.S. colorectal surgeons received hands-on training this month using the da Vinci Surgical System at the fourth-annual Colorectal Fellowship Training Program, sponsored by Intuitive Surgical. Intuitive Surgical hosted 88 residents this year, up from nine ...More
Cells Eating Poison: A Method for Killing Colon Cancer
These days, cancer researchers aim to design targeted and specific therapy—those that kill cancer but spare the surrounding tissue. Immunotoxins, which use cancer-targeted antibodies linked to deadly toxins such as ricin, are one such therapy. However, few have ...More
Should Medicare Cover Virtual Colonoscopy Coverage?
The evidence standard that the Centers for Medicare & Medicaid Services (CMS) used to approve Medicare coverage of a stool DNA colorectal cancer (CRC) screening test, under a new joint approval process with the Food and Drug Administration, should be applied to CT ...More
ASGE Supports New Screening Program for Health Centers
The American Society for Gastrointestinal Endoscopy (ASGE), a member of the National Colorectal Cancer Roundtable (NCCRT), is a partner in the new NCCRT program aimed at improving colorectal cancer screening rates and access to specialty care in community health centers. ...More
Mayo Clinic Is First Healthcare System to Offer Cologuard
Mayo Clinic will be the first health system to offer Cologuard, the only FDA-approved noninvasive stool DNA screening test for colorectal cancer. Cologuard will be available to patients through their primary care physicians at Mayo Clinic. ...More
Tailoring Bowel Preps: Patient Activation and Navigation
Research has improved the quality of patient instructions for colon preps, but it’s tough reaching that goal of a high percentage of “excellent” rated colon cleanses. For endoscopy suite staff currently charged with prep improvement projects, concepts like ...More
Do Gut Bacteria Rule Our Minds?
It sounds like science fiction, but it seems that bacteria within us―which outnumber our own cells about 100-fold―may very well be affecting both our cravings and moods to get us to eat what they want, and often are driving us toward obesity. ...More
Flexible Sigmoidoscopy Reduces Colorectal-Cancer Incidence, Rate of Death
Among about 100,000 study participants, screening with flexible sigmoidoscopy resulted in a reduced incidence and rate of death of colorectal cancer, compared to no screening, according to a study in the August 13 issue of JAMA. ...More
Growing Human GI Cells May Lead to Personalized Treatments
A method of growing human cells from tissue removed from a patient’s gastrointestinal (GI) tract eventually may help scientists develop tailor-made therapies for inflammatory bowel disease and other GI conditions. ...More